Compositions, methods and related uses for cleaving modified DNA
View Patent ↗Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X) 10 YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.
1. A method for analyzing methylation of a genome, comprising:
(a) enzymatically cleaving a sample comprising DNA from the genome to obtain a set of similar sized double stranded fragments that are characterized by i. staggered ends; and ii. a centrally located methylated or hydroxymethylated cytosine proximal to guanine;
(b) sequencing the fragments; and
(c) mapping the sequences obtained in step (b) onto a sequence map of the genome, thereby determining the location of a methylated or hydroxymethylated cytosine in the genome.
2. The method of claim 1 , wherein the method comprises separating the set of similarly sized fragments from uncleaved DNA prior to sequencing.
3. The method of claim 1 , wherein the genome is a mammalian genome.
4. The method of claim 1 , wherein the genome is a human genome.
5. The method of claim 1 , wherein the similar sized fragments are less than 60 nucleotides in size.
6. The method of claim 1 , wherein the similar sized fragments have a size in the range of 28-36 nucleotides.
7. The method of claim 1 , wherein the methylated cytosine is located within 30 nucleotides from one end of a fragment.
8. The method of claim 1 , wherein the centrally positioned methylated cytosine is in a CpG dinucleotide.
9. The method of claim 1 , wherein the centrally positioned methylated cytosine is in a CNG trinucleotide.
10. The method according to claim 1 , further comprising:
counting the distribution of CG, CHG and CHH sites (H=C/A/T).
11. The method according to claim 10 , further comprising annotating a whole genome map with the distribution of CG, CHG and CHH sites (H=C/A/T);
sequencing depth at each methylated cytosine; and optionally with chromosome number;
chromosomal location number; strand information; and enzyme recognition sites.
12. The method of claim 1 , wherein the enzymatically cleaving is done by a restriction endonuclease having an amino acid sequence that is at least 90% identical to SEQ ID NO:38; SEQ ID NO:29; SEQ ID NO:25; SEQ ID NO:27; SEQ ID NO:31; or SEQ ID NO:26.